| Andrea Arguello, MD | |
|
3501 N Macarthur Blvd Ste 500, Irving, TX 75062-3675 | |
| (972) 256-3700 | |
| Not Available |
| Full Name | Andrea Arguello |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 13 Years |
| Location | 3501 N Macarthur Blvd Ste 500, Irving, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174813927 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | P5507 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Macarthur Medical Center Pllc | 8426102625 | 21 |
News Archive
Texas is now among more than a dozen states that have cracked down on the practice of surprise medical billing.
Federal laws that motivate or require drug and biologic developers to conduct pediatric studies have yielded beneficial information to guide the use of medications in children, says a new report by the Institute of Medicine. Still, studies involving children continue to be limited, especially in certain areas such as medications' use in newborns and long-term safety and effectiveness in children.
A systematic review published today in The Cochrane Library finds that in well-nourished adults current evidence does not support selenium for preventing heart disease.
CPEX Pharmaceuticals, Inc. today confirmed that Arcadia Capital Advisors, LLC and its principal Richard Rofé, who hold approximately 12% of outstanding shares, have filed with the Securities and Exchange Commission (SEC) notice of intention of Mr. Rofé to make an unsolicited contingent offer to purchase the remaining shares of common stock of CPEX for $14.00 per share. Mr. Rofé indicated that any offer would require the CPEX Board of Directors to redeem the Rights under CPEX Shareholder Rights Plan.
› Verified 9 days ago
| Entity Name | Macarthur Medical Center Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326320367 PECOS PAC ID: 8426102625 Enrollment ID: O20090824000109 |
News Archive
Texas is now among more than a dozen states that have cracked down on the practice of surprise medical billing.
Federal laws that motivate or require drug and biologic developers to conduct pediatric studies have yielded beneficial information to guide the use of medications in children, says a new report by the Institute of Medicine. Still, studies involving children continue to be limited, especially in certain areas such as medications' use in newborns and long-term safety and effectiveness in children.
A systematic review published today in The Cochrane Library finds that in well-nourished adults current evidence does not support selenium for preventing heart disease.
CPEX Pharmaceuticals, Inc. today confirmed that Arcadia Capital Advisors, LLC and its principal Richard Rofé, who hold approximately 12% of outstanding shares, have filed with the Securities and Exchange Commission (SEC) notice of intention of Mr. Rofé to make an unsolicited contingent offer to purchase the remaining shares of common stock of CPEX for $14.00 per share. Mr. Rofé indicated that any offer would require the CPEX Board of Directors to redeem the Rights under CPEX Shareholder Rights Plan.
› Verified 9 days ago
| Entity Name | Obhg Texas Holdings Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083917769 PECOS PAC ID: 3577713072 Enrollment ID: O20121018000279 |
News Archive
Texas is now among more than a dozen states that have cracked down on the practice of surprise medical billing.
Federal laws that motivate or require drug and biologic developers to conduct pediatric studies have yielded beneficial information to guide the use of medications in children, says a new report by the Institute of Medicine. Still, studies involving children continue to be limited, especially in certain areas such as medications' use in newborns and long-term safety and effectiveness in children.
A systematic review published today in The Cochrane Library finds that in well-nourished adults current evidence does not support selenium for preventing heart disease.
CPEX Pharmaceuticals, Inc. today confirmed that Arcadia Capital Advisors, LLC and its principal Richard Rofé, who hold approximately 12% of outstanding shares, have filed with the Securities and Exchange Commission (SEC) notice of intention of Mr. Rofé to make an unsolicited contingent offer to purchase the remaining shares of common stock of CPEX for $14.00 per share. Mr. Rofé indicated that any offer would require the CPEX Board of Directors to redeem the Rights under CPEX Shareholder Rights Plan.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Arguello, MD Po Box 612526, Dallas, TX 75261-2526 Ph: () - | Andrea Arguello, MD 3501 N Macarthur Blvd Ste 500, Irving, TX 75062-3675 Ph: (972) 256-3700 |
News Archive
Texas is now among more than a dozen states that have cracked down on the practice of surprise medical billing.
Federal laws that motivate or require drug and biologic developers to conduct pediatric studies have yielded beneficial information to guide the use of medications in children, says a new report by the Institute of Medicine. Still, studies involving children continue to be limited, especially in certain areas such as medications' use in newborns and long-term safety and effectiveness in children.
A systematic review published today in The Cochrane Library finds that in well-nourished adults current evidence does not support selenium for preventing heart disease.
CPEX Pharmaceuticals, Inc. today confirmed that Arcadia Capital Advisors, LLC and its principal Richard Rofé, who hold approximately 12% of outstanding shares, have filed with the Securities and Exchange Commission (SEC) notice of intention of Mr. Rofé to make an unsolicited contingent offer to purchase the remaining shares of common stock of CPEX for $14.00 per share. Mr. Rofé indicated that any offer would require the CPEX Board of Directors to redeem the Rights under CPEX Shareholder Rights Plan.
› Verified 9 days ago
John J Zavaleta, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3501 N Macarthur Blvd, Ste 350, Irving, TX 75062 Phone: 972-257-5300 Fax: 972-257-5321 | |
Jeffrey Wang, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3501 N Macarthur Blvd Ste 500, Irving, TX 75062 Phone: 972-256-3700 Fax: 866-630-6348 | |
Alyssa Dawn Price, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3501 N Macarthur Blvd Ste 500, Irving, TX 75062 Phone: 972-256-3700 Fax: 866-630-6348 | |
Kristen Richeson Carmichael, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6750 N Macarthur Blvd, Suite 304, Irving, TX 75039 Phone: 972-253-2530 Fax: 972-253-4218 | |
Richard Downs Wagner, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3501 N Macarthur Blvd Ste 500, Irving, TX 75062 Phone: 972-256-3700 Fax: 866-630-6348 | |
Dr. John R Hanson, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3501 N Macarthur Blvd, Ste. 350, Irving, TX 75062 Phone: 972-257-5300 Fax: 972-257-5322 |